Why the study?
Is a software-based antitachycardia pacemaker safe and effective for terminating recurrent symptomatic supraventricular and ventricular tachycardias?
Population
14 patients with recurrent symptomatic tachycardias with a mean symptom duration of 8 +/- 4 years and mean…
Design
Case_series
Follow-up
30.5 +/- 10.6 months
Authors
Loading...
Should not yet change practice; leaves open questions on long-term safety and broader efficacy in prospective studies.
Is a software-based antitachycardia pacemaker safe and effective for terminating recurrent symptomatic supraventricular and ventricular tachycardias?
The software-based antitachycardia pacemaker provided reliable detection and termination of recurrent tachycardias, serving as a valuable adjunctive therapy in selected patients.
Fromer et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: